HAVCR2 and glioblastoma: In contrast, HAVCR2 predicted worse prognosis in GBM (Figure 2N), GBMLGG (Figures 2B,G,O), LGG (Figures 2D,I), PRAD (Figure 2Q), and UVM (Figures 2F,L).